Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)

TPEX:4186 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,071	1,418	1,485	1,593	1,674	2,282
Market Cap Growth	-23.72%	-4.54%	-6.78%	-4.84%	-26.63%	53.00%
Enterprise Value	1,213	1,566	1,648	1,716	1,780	2,522
Last Close Price	11.90	15.75	16.50	17.70	18.60	25.35
PE Ratio	46.52	61.97	-	502.52	-	-
PS Ratio	2.88	4.00	4.70	5.01	6.88	9.69
PB Ratio	4.24	5.53	6.35	6.51	6.93	6.36
P/TBV Ratio	4.24	5.53	6.35	6.61	7.24	6.81
P/FCF Ratio	209.92	324.59	2226.39	-	-	-
P/OCF Ratio	85.93	170.23	117.78	-	-	-
EV/Sales Ratio	3.26	4.42	5.22	5.39	7.31	10.70
EV/EBITDA Ratio	18.92	27.80	71.28	55.41	-	-
EV/EBIT Ratio	27.86	37.95	677.30	225.46	-	-
EV/FCF Ratio	237.66	358.55	2470.58	-	-	-
Debt / Equity Ratio	1.01	0.90	1.31	1.14	1.03	0.74
Debt / EBITDA Ratio	3.98	3.71	10.84	7.81	-	-
Debt / FCF Ratio	50.01	52.59	460.63	-	-	-
Asset Turnover	0.53	0.50	0.43	0.45	0.32	0.32
Inventory Turnover	5.70	5.47	5.27	5.29	4.83	4.21
Quick Ratio	0.78	0.85	0.74	0.91	0.93	1.35
Current Ratio	0.90	0.96	0.82	1.07	1.09	1.61
Return on Equity (ROE)	9.72%	9.33%	-4.46%	1.30%	-39.48%	-31.18%
Return on Assets (ROA)	3.91%	3.62%	0.21%	0.67%	-8.36%	-7.14%
Return on Invested Capital (ROIC)	11.04%	11.17%	0.67%	1.88%	-28.58%	-22.45%
Return on Capital Employed (ROCE)	10.20%	9.40%	0.60%	1.60%	-21.90%	-13.90%
Earnings Yield	2.18%	1.61%	-0.72%	0.20%	-7.08%	-3.79%
FCF Yield	0.48%	0.31%	0.04%	-1.75%	-3.78%	-4.58%
Buyback Yield / Dilution	-	-	-	-	-11.05%	-6.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.